Quick answer: Immigrant success in the U.S. goes far beyond Silicon Valley. Immigrants have won 40% of the Nobel Prizes awarded to Americans in chemistry, medicine, and physics since 2000, make up roughly a quarter to a third of practicing U.S. physicians, and have built some of the country's largest retail brands, led U.S. foreign policy, and become some of its most recognized humanitarians. The stories below are all independently documented.
The Numbers Behind the Stories
| Field | Statistic | Source |
|---|---|---|
| Nobel Prizes (chemistry, medicine, physics) | Immigrants won 40% of American Nobel Prizes in these fields since 2000; 36% since 1901 | National Foundation for American Policy |
| 2025 Nobel Prizes | 3 of 6 U.S. science laureates were immigrants | National Foundation for American Policy / Forbes |
| Nobel Prize in Economics | Immigrants won 31% of American economics Nobel Prizes since 2000 | National Foundation for American Policy |
| U.S. physicians | Up to 28% of practicing U.S. physicians are immigrants; international medical graduates make up about 25% of the physician workforce | Peer-reviewed physician workforce research |
| Geriatric medicine and nephrology | Immigrant physicians make up about half of active practitioners in these specialties | Physician workforce research |
Four Documented Stories
Katalin Karikó — Nobel Prize in Physiology or Medicine, 2023. Karikó immigrated to the U.S. from Hungary in 1985 to take a postdoctoral position at Temple University, after her research funding at home ran out. For decades, her work on messenger RNA (mRNA) was dismissed by much of the scientific establishment; at one point she was demoted and nearly pushed out of her position. She continued the research anyway, and her breakthrough discovery with collaborator Drew Weissman on modified mRNA became the scientific foundation for the Pfizer-BioNTech and Moderna COVID-19 vaccines. In 2023, the two shared the Nobel Prize in Physiology or Medicine.
Do Won and Jin Sook Chang — founders of Forever 21. The Changs immigrated from South Korea in 1981 with very little English and worked multiple jobs simultaneously, including as a janitor, gas station attendant, and hairdresser, while saving toward a business of their own. In 1984, three years after arriving, they opened their first store, Fashion 21, in Los Angeles with roughly $11,000 in savings; it generated $700,000 in revenue in its first year. The company grew into Forever 21, a global fashion retailer with billions in annual sales at its peak. Worth noting for accuracy: the company later filed for bankruptcy in 2019 and again in 2025, a reminder that even major immigrant-built success stories aren't guaranteed to be permanent, though the Changs' personal journey from minimum-wage jobs to building a multi-billion-dollar retail brand remains a widely cited example of immigrant entrepreneurship.
Madeleine Albright — first female U.S. Secretary of State. Albright's family fled Czechoslovakia twice, first from the Nazis in 1939 and again from the Soviet-backed communist takeover in 1948, arriving in the U.S. as refugees when she was 11 years old. The family settled in Denver, where her father took a university professorship. Albright went on to serve as U.S. Ambassador to the United Nations and, in 1997, became the first woman to serve as U.S. Secretary of State, overseeing major foreign policy initiatives including NATO expansion and Middle East peace efforts.
Dikembe Mutombo — NBA Hall of Famer and humanitarian. Mutombo left the Democratic Republic of Congo in 1987 on a scholarship to attend Georgetown University, originally intending to become a doctor. Georgetown's basketball coach recruited him based on his height and wingspan, and Mutombo went on to an 18-year NBA career, becoming an eight-time All-Star and four-time Defensive Player of the Year. He later invested millions of dollars in building a hospital in his home country and became the NBA's first Global Ambassador, using his platform for humanitarian work until his death in 2024.
What Connects These Stories
These four people arrived in the U.S. through very different routes, a postdoctoral research position, an entrepreneurial move with almost no savings, refugee resettlement, and a university scholarship, decades apart from each other and long before today's visa categories existed in their current form. What they share isn't a specific visa type; it's that none of their outcomes were visible or guaranteed at the point they arrived. Karikó was nearly forced out of her lab. The Changs started with $11,000 and no fluent English. Albright arrived as an 11-year-old refugee. Mutombo hadn't touched a basketball competitively before Georgetown recruited him. Success, in each case, took years to decades to materialize.
Every Story Starts With a Legal Pathway
Behind each of these outcomes was a specific, and often uncertain, immigration process: a postdoctoral visa, refugee resettlement, a student visa, an employment petition. None of it was guaranteed, and all of it required navigating a legal system that hasn't gotten simpler over time. If you're early in your own immigration journey, understanding your options clearly from the start matters more than any individual success story.
This article is for general informational purposes and does not constitute legal advice. Historical details are drawn from public reporting and may not reflect current visa categories or requirements. Contact our office to discuss your specific situation.
Sources: National Foundation for American Policy — Immigrants and Nobel Prizes, 1901–2025 · Forbes — Half of the 2025 U.S. Nobel Prize Winners in Science Are Immigrants · Scientific American — Katalin Karikó's Nobel Prize-Winning Work on mRNA · Forbes — Exclusive Interview With Forever 21's Do Won Chang · Wikipedia — Do Won and Jin Sook Chang · Wilson Center — Madeleine Albright Tells Her Story · Alma — Dikembe Mutombo's Immigration Story · Atlanta Journal-Constitution — How NBA Star Dikembe Mutombo Came to Save Untold Lives in Africa
Frequently Asked Questions
Do these stories reflect typical immigration outcomes?
No, and it's worth being direct about that. These are exceptional individual outcomes, not representative averages. They're included here because they're well documented and independently verifiable, not because they predict any individual applicant's future.
What visa categories would these pathways correspond to today?
It varies, and directly mapping decades-old immigration journeys onto today's categories isn't always accurate, since immigration law has changed substantially over time. Karikó's postdoctoral fellowship path today would likely involve a J-1 or H-1B before any green card process. Albright's family came through refugee resettlement, a distinct humanitarian pathway unrelated to employment or investment visas. An attorney can explain which modern category best fits a specific situation.
Are immigrant physicians filling gaps in U.S. healthcare specifically?
Yes. Research shows immigrant physicians make up a disproportionate share of practitioners in certain specialties and in rural or underserved areas, where they're sometimes the only primary care providers available.
Why include a story about a company that later went bankrupt?
Because accuracy matters more than a tidy narrative. The Changs' personal success, arriving with almost nothing and building a multi-billion-dollar company, is well documented and remains true regardless of what happened to the company decades later.
This article is for general informational purposes only and does not constitute legal advice. Immigration law and agency policy are subject to change; consult a licensed immigration attorney about your specific case. Immigration Ascent is a division of Gillespie, Shields and Taylor. Content on this website is for general information and does not constitute legal advice. Reading this site or contacting us does not create an attorney-client relationship. Communications are governed by our Privacy Policy and Terms of Service. Contact: pranavsai52@gmail.com.